01045nam0 2200313 450 00003111220130215114716.084-376-0411-720120302d1983----km-y0itaa50------baspaESSoledadesGaleríasOtros poemasAntonio Machadoedición de Geoffrey RibbansMadridCatedra1983280 p.18 cmLetras Hispánicas1802001Letras Hispánicas180Machado,Antonio132275Ribbans,GeoffreyITUniversità della Basilicata - B.I.A.REICATunimarc000031112Otros poemas94333Soledades94331Galerías1529171UNIBASLETTERESTD0730020120302BAS011052ATR2020130215BAS011147BAS01BAS01BOOKBASA1Polo Storico-UmanisticoGENCollezione generaleFP/1732517325L173252012030202Prestabile Generale03382nam 2200649Ia 450 991077922980332120230721020732.00-19-174006-30-19-960718-41-283-58126-497866138937100-19-157545-3(CKB)2550000000105507(EBL)975600(OCoLC)801363650(SSID)ssj0000627964(PQKBManifestationID)12276471(PQKBTitleCode)TC0000627964(PQKBWorkID)10701500(PQKB)10109319(StDuBDS)EDZ0000091507(Au-PeEL)EBL975600(CaPaEBR)ebr10581627(CaONFJC)MIL389371(MiAaPQ)EBC975600(EXLCZ)99255000000010550720090415d2008 uy 0engurcn|||||||||txtccrVaccines for the prevention of cervical cancer[electronic resource] /edited by Peter L. Stern and Henry C. KitchenerOxford Oxford University Press20081 online resource (170 p.)Oxford oncology libraryDescription based upon print version of record.0-19-954345-3 Includes bibliographical references and index.Contents; Preface; Contributors; Abbreviations; Glossary; Part 1-Prevention and current treatment; 1 The UK cervical screening programme; 2 Management of cervical intraepithelial neoplasia (CIN); Part 2-HPV and disease; 3 Role of HPV in cervical carcinogenesis; 4 HPV and genital cancer: the essential epidemiology; 5 The role of HPV testing in cervical screening; Part 3-Immune control of HPV infection in cervical neoplasia; 6 Natural immune control of HPV infection; 7 Prophylactic HPV vaccines: pre-clinical and proof of principle studies; 8 Prophylactic HPV vaccination: current status9 Introduction of HPV prophylactic vaccination Part 4-Challenges and future developments; 10 HPV vaccination in the developing world; 11 Screening post vaccination; 12 Second-generation HPV prophylactic vaccines; 13 Therapeutic HPV vaccines; 14 Conclusion; Index;Cervical cancer is the second most common form of cancer found in women and it is responsible for more than a quarter of a million deaths worldwide each year. With approximately 70% of cervical cancers now known to be caused by two types of the human papilloma virus (HPV), there is great interest surrounding the approval of the first preventative vaccines for clinical use. Despite this excitement, many questions remain about how the new vaccines should best be implemented and how cervical cancer screening will change following vaccination.Part of the Oxford Oncology Library series, this practiceOxford oncology library.Cervix uteriCancerPreventionCancer vaccinesCervix uteriCancerPrevention.Cancer vaccines.616.99/466Stern Peter L1461977Kitchener Henry C1461978MiAaPQMiAaPQMiAaPQBOOK9910779229803321Vaccines for the prevention of cervical cancer3670829UNINA